254 related articles for article (PubMed ID: 37111768)
1. Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective.
Briki M; André P; Thoma Y; Widmer N; Wagner AD; Decosterd LA; Buclin T; Guidi M; Carrara S
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111768
[TBL] [Abstract][Full Text] [Related]
2. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.
Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E
Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915
[TBL] [Abstract][Full Text] [Related]
3. Point-of-Care Therapeutic Drug Monitoring for Precision Dosing of Immunosuppressive Drugs.
Taddeo A; Prim D; Bojescu ED; Segura JM; Pfeifer ME
J Appl Lab Med; 2020 Jul; 5(4):738-761. PubMed ID: 32533157
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring in cancer--are we missing a trick?
Bardin C; Veal G; Paci A; Chatelut E; Astier A; Levêque D; Widmer N; Beijnen J
Eur J Cancer; 2014 Aug; 50(12):2005-9. PubMed ID: 24878063
[TBL] [Abstract][Full Text] [Related]
5. Optimizing therapeutic drug monitoring in inflammatory bowel disease: a focus on therapeutic monoclonal antibodies.
Papamichael K; Cheifetz AS
Expert Opin Drug Metab Toxicol; 2021 Dec; 17(12):1423-1431. PubMed ID: 34996330
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices.
Smita P; Narayan PA; J K; Gaurav P
Front Oncol; 2022; 12():1015200. PubMed ID: 36568145
[TBL] [Abstract][Full Text] [Related]
7. A framework for economic evaluation of therapeutic drug monitoring-guided dosing in oncology.
Erku D; Schneider J; Scuffham P
Pharmacol Res Perspect; 2021 Oct; 9(5):e00862. PubMed ID: 34546005
[TBL] [Abstract][Full Text] [Related]
8. Intravenous Vancomycin Therapeutic Drug Monitoring in Children: Evaluation of a Pharmacy-Driven Protocol and Collaborative Practice Agreement.
Olson J; Hersh AL; Sorensen J; Zobell J; Anderson C; Thorell EA
J Pediatric Infect Dis Soc; 2020 Jul; 9(3):334-341. PubMed ID: 31344233
[TBL] [Abstract][Full Text] [Related]
9. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
[TBL] [Abstract][Full Text] [Related]
10. Individualized dosing of vancomycin in geriatric patients.
Suchánková H; Lečbychová K; Strojil J; Fürst T
Epidemiol Mikrobiol Imunol; 2020; 69(4):172-180. PubMed ID: 33445941
[TBL] [Abstract][Full Text] [Related]
11. Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
Matsumoto K; Oda K; Shoji K; Hanai Y; Takahashi Y; Fujii S; Hamada Y; Kimura T; Mayumi T; Ueda T; Nakajima K; Takesue Y
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335866
[TBL] [Abstract][Full Text] [Related]
12. From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics.
Wicha SG; Märtson AG; Nielsen EI; Koch BCP; Friberg LE; Alffenaar JW; Minichmayr IK;
Clin Pharmacol Ther; 2021 Apr; 109(4):928-941. PubMed ID: 33565627
[TBL] [Abstract][Full Text] [Related]
13. Utility, promise, and limitations of liquid chromatography-mass spectrometry-based therapeutic drug monitoring in precision medicine.
Gaspar VP; Ibrahim S; Zahedi RP; Borchers CH
J Mass Spectrom; 2021 Nov; 56(11):e4788. PubMed ID: 34738286
[TBL] [Abstract][Full Text] [Related]
14. Precision sirolimus dosing in children: The potential for model-informed dosing and novel drug monitoring.
Shen G; Moua KTY; Perkins K; Johnson D; Li A; Curtin P; Gao W; McCune JS
Front Pharmacol; 2023; 14():1126981. PubMed ID: 37021042
[TBL] [Abstract][Full Text] [Related]
15. Appropriate dosing of antiarrhythmic drugs in Japan requires therapeutic drug monitoring.
Takada M; Goto T; Kotake T; Saito M; Kawato N; Nakai M; Gunji T; Shibakawa M
J Clin Pharm Ther; 2005 Feb; 30(1):5-12. PubMed ID: 15658999
[TBL] [Abstract][Full Text] [Related]
16. Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
Fournier A; Eggimann P; Pagani JL; Revelly JP; Decosterd LA; Marchetti O; Pannatier A; Voirol P; Que YA
Burns; 2015 Aug; 41(5):956-68. PubMed ID: 25678084
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring of psychotropic drugs in China: a nationwide survey.
Guo W; Guo GX; Sun C; Zhang J; Rong Z; He J; Sun ZL; Yan F; Tang YL; Wang CY; Li WB
Ther Drug Monit; 2013 Dec; 35(6):816-22. PubMed ID: 24263641
[TBL] [Abstract][Full Text] [Related]
18. On precision dosing of oral small molecule drugs in oncology.
Lyashchenko AK; Cremers S
Br J Clin Pharmacol; 2021 Feb; 87(2):263-270. PubMed ID: 32621551
[TBL] [Abstract][Full Text] [Related]
19. Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine.
Groenland SL; Mathijssen RHJ; Beijnen JH; Huitema ADR; Steeghs N
Eur J Clin Pharmacol; 2019 Sep; 75(9):1309-1318. PubMed ID: 31175385
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) Population.
Shukla P; Goswami S; Keizer RJ; Winger BA; Kharbanda S; Dvorak CC; Long-Boyle J
Front Pharmacol; 2020; 11():888. PubMed ID: 32714184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
